Cargando…

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis

This study aimed to perform a meta-analysis to determine the efficacy and safety of emricasan. Nine databases were searched for clinical trials investigating the efficacy of emricasan treatment in patients with liver cirrhosis or fibrosis. A manual search was conducted to identify the missing trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Li-ya, Li, Shu-qin, Tang, Li-xin, Li, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183342/ https://www.ncbi.nlm.nih.gov/pubmed/34133478 http://dx.doi.org/10.6061/clinics/2021/e2409

Ejemplares similares

Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
por: Garcia‐Tsao, Guadalupe, et al.
Publicado: (2018)

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
por: Gracia‐Sancho, Jordi, et al.
Publicado: (2019)

D020 ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19.
por: Alpan, O., et al.
Publicado: (2021)

Genomics and proteomics in liver fibrosis and cirrhosis
por: Hannivoort, Rebekka A, et al.
Publicado: (2012)

Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease
por: Shiffman, Mitchell, et al.
Publicado: (2018)

Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis
por: Lu, Wenming, et al.
Publicado: (2023)

Histopathological evaluation of liver fibrosis and cirrhosis regression
por: Lo, Regina C., et al.
Publicado: (2017)

A review of liver fibrosis and cirrhosis regression
por: Lee, Michael J.
Publicado: (2023)

Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
por: Roni, D. Ajith, et al.
Publicado: (2013)

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis
por: Dong, Shu, et al.
Publicado: (2015)

Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease
por: Ding, Rongrong, et al.
Publicado: (2021)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Personalized management of cirrhosis by non-invasive tests of liver fibrosis
por: Wong, Grace Lai-Hung, et al.
Publicado: (2015)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
por: Xie, Zhi-Qin, et al.
Publicado: (2021)

Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020)

Complex Cell Type-Specific Roles of Autophagy in Liver Fibrosis and Cirrhosis
por: Hung, Tzu-Min, et al.
Publicado: (2020)

Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE
por: Wan, Lijun, et al.
Publicado: (2023)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis
por: Wang, Le, et al.
Publicado: (2017)

A Case of the Safety and Efficacy of Guselkumab in Psoriasis with Alcoholic Liver Cirrhosis
por: Nam, Hyun Min, et al.
Publicado: (2021)

Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
por: Liu, Pinyan, et al.
Publicado: (2022)

Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study
por: Qi, Xingshun, et al.
Publicado: (2016)

Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis
por: Chen, Huan, et al.
Publicado: (2021)

Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study
por: Wang, Ming-Fang, et al.
Publicado: (2018)

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy
por: Procopet, Bogdan, et al.
Publicado: (2017)

Predictors of liver failure in primary biliary cirrhosis
por: Zhao, Pan, et al.
Publicado: (2015)

The spleen in liver cirrhosis: revisiting an old enemy with novel targets
por: Li, Liang, et al.
Publicado: (2017)

The content of hydrogen sulfide in plasma of cirrhosis rats combined with portal hypertension and the correlation with indexes of liver function and liver fibrosis
por: Wei, Weiwei, et al.
Publicado: (2017)

Adipokines in Liver Cirrhosis
por: Buechler, Christa, et al.
Publicado: (2017)

Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: A Meta-Analysis Based on Seven Controlled Trials
por: Ma, Xiang-Rui, et al.
Publicado: (2015)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study
por: Qi, Xingshun, et al.
Publicado: (2015)

Regression of liver fibrosis: evidence and challenges
por: Sun, Ya-Meng, et al.
Publicado: (2020)

HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis
por: Huang, Yi, et al.
Publicado: (2023)

Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis
por: Qi, Xiaolong, et al.
Publicado: (2018)

Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis
por: Chen, Si-Hai, et al.
Publicado: (2020)

Feasibility and Efficacy of Transient Elastography using the XL probe to diagnose liver fibrosis and cirrhosis: A meta-analysis
por: Xia, Bingqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cs4b4ekqap6fhp8i9q5vs44086